Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01799681
Other study ID # approvalletter_20110823001
Secondary ID
Status Completed
Phase N/A
First received February 21, 2013
Last updated March 18, 2015
Start date August 2011
Est. completion date December 2014

Study information

Verified date March 2015
Source The Hong Kong Polytechnic University
Contact n/a
Is FDA regulated No
Health authority Hong Kong: University Grants Committee
Study type Interventional

Clinical Trial Summary

To determine whether the 8-week Hopeful Outdoor Parkinson's Exercise (HOPE) Program would be effective in improving balance performance, physical functions, gait parameter, balance confidence, health-related quality-of-life, disease-specific motor performance and fall-related outcomes in Parkinson's disease (PD) non-fallers and single fallers.


Description:

Previous studies demonstrated that multi-modal balance training program was effective in improving balance performance in people with PD. However they did not include all the balance domains and outdoor fall-prone activities have been overlooked. We designed a task- and context-specific balance training program based on the framework of the Balance Evaluation Systems Test (BESTest) to target all six balance domains including biomechanical constraints, stability limits and verticality, anticipatory postural adjustments, reactive postural responses, sensori-motor integration and dynamic gait control.


Recruitment information / eligibility

Status Completed
Enrollment 84
Est. completion date December 2014
Est. primary completion date January 2014
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 85 Years
Eligibility Inclusion Criteria:

- diagnosed with PD by a neurologist (Fahn and Elton, 1987);

- aged 30 to 85 years;

- at modified Hoehn and Yahr (H&Y) stage 1.5 to 3 (Hoehn and Yahr ,1967; Goetz et al., 2004);

- able and willing to give written consent for participation in the study;

- living at home in the community;

- able to walk independently for 30 metres with or without an assistive device.

Exclusion Criteria:

- any neurological conditions other than PD;

- significant musculoskeletal or cardiopulmonary diseases;

- other disorders that may affect balance or locomotion;

- taken any structured behavioral or exercise programs in the past 3 months

- or they are receiving regular physical rehabilitation at present;

- unstable condition on anti-parkinsonian medications;

- surgical interventions for PD;

- communication or cognitive deficits with mini-mental state examination, (MMSE) <24/30 (Folstein et al., 1975);

- a history of more than two falls in the previous 12 months.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
an 8-week blended indoor-outdoor exercise program
stretching, strength and functional training, Balance Dance, Modified Wing Chun, Square stepping exercise, and fall-prone activities practice
an 8-week upper limb and hand exercise program
upper limb stretching and strengthening, hand agility exercises, knot tying and Chinese calligraphy

Locations

Country Name City State
China The Hong Kong Polytechnic University Hong Kong SAR

Sponsors (1)

Lead Sponsor Collaborator
The Hong Kong Polytechnic University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other Changes from baseline Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) III at post 4-week training, post 8-week training, 6-and 12-month follow-ups 12 months after intervention No
Other Ratios of total and injurious non-fallers to fallers 12 months after intervention No
Other Total and Injurious fall rates 12 months after intervention No
Other The time to first fall and time to first injurious fall 12 months after intervention No
Primary Changes from baseline Balance Systems Evaluation Test total and subsection scores at post 4-week training, post 8-week training, 6- and 12-month follow-ups 12 months after intervention No
Secondary Changes from baseline comfortable gait speed at post 4-week training, post 8-week training, 6- and 12-month follow-ups 12 months after intervention No
Secondary Changes from baseline dual task timed-up-and-go time at post 4-week training, post 8-week training, 6- and 12-month follow-ups 12 months after intervention No
Secondary Changes from baseline timed-up-and-go time at post 4-week training, post 8-week training, 6- and 12-month follow-ups 12 months after intervention No
Secondary Changes from baseline five-times-sit-to-stand time at post 4-week training, post 8-week training, 6- and 12-month follow-ups 12 months after intervention No
Secondary Changes from baseline one-leg stance time at post 4-week training, post 8-week training, 6- and 12-month follow-ups 12 months after intervention No
Secondary Changes from baseline Activities-specific Balance Confidence Scale at post 4-week training, post 8-week training, 6- and 12-month follow-ups 12 months after intervention No
Secondary Changes from baseline Parkinson's disease Questionnaire (PDQ-39) at post 4-week training, post 8-week training, 6- and 12-month follow-ups 12 months after intervention No
See also
  Status Clinical Trial Phase
Completed NCT02915848 - Long-term Stability of LFP Recorded From the STN and the Effects of DBS
Recruiting NCT03648905 - Clinical Laboratory Evaluation of Chronic Autonomic Failure
Terminated NCT02688465 - Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). Phase 4
Completed NCT05040048 - Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Active, not recruiting NCT04006210 - Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Phase 3
Completed NCT02562768 - A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease Phase 1
Completed NCT00105521 - Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Phase 3
Completed NCT00105508 - Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Phase 3
Recruiting NCT06002581 - Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease N/A
Completed NCT02236260 - Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation N/A
Completed NCT00529724 - Body Weight Gain, Parkinson, Subthalamic Stimulation Phase 2
Active, not recruiting NCT05699460 - Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
Completed NCT03703570 - A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations Phase 2
Completed NCT03462680 - GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures N/A
Completed NCT02837172 - Diagnosis of PD and PD Progression Using DWI
Not yet recruiting NCT04046276 - Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease N/A
Recruiting NCT02952391 - Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol N/A
Active, not recruiting NCT02937324 - The CloudUPDRS Smartphone Software in Parkinson's Study. N/A
Completed NCT02927691 - Novel Management of Airway Protection in Parkinson's Disease: A Clinical Trial Phase 2
Terminated NCT02894567 - Evaluation of Directional Recording and Stimulation Using spiderSTN N/A